News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Insider Information

Epigenomics AG: Reduction of principal amount of planned mandatory convertible bond to up to EUR 16.5 million and of conversion price to EUR 1.10 per share

Epigenomics AG / Key word(s): Issue of Debt/Corporate ActionEpigenomics AG: Reduction of principal amount of planned mandatory convertible bond to up to EUR 16.5 million and of conversion price to EUR 1.10 per share 20-Aug-2021 / 10:41 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by […]

Read more

Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance

Epigenomics AG / Key word(s): Strategic Company Decision/Change in ForecastEpigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance 17-Aug-2021 / 21:00 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for […]

Read more

Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million

Epigenomics AG / Key word(s): Bond/FinancingEpigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million 11-Jun-2021 / 21:05 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]

Read more

Epigenomics AG successfully completes capital increase

Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG successfully completes capital increase 18-May-2021 / 08:51 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT FOR PUBLICATION, DISTRIBUTION […]

Read more

Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders

Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders 27-Apr-2021 / 17:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible […]

Read more

Epigenomics AG is Evaluating M&A Options

Epigenomics AG / Key word(s): Strategic Company DecisionEpigenomics AG is Evaluating M&A Options 25-March-2021 / 10:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT TO BE […]

Read more